Aparicio-Soto Marina, Riedel Franziska, Leddermann Melanie, Bacher Petra, Scheffold Alexander, Kuhl Heiner, Timmermann Bernd, Chudakov Dmitriy M, Molin Sonja, Worm Margitta, Heine Guido, Thierse Hermann-Josef, Luch Andreas, Siewert Katherina
Department of Chemical and Product Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Institute of Immunology, Christian-Albrechts Universität zu Kiel and Universitätsklinik Schleswig-Holstein, Kiel, Germany.
Allergy. 2020 Oct;75(10):2574-2586. doi: 10.1111/all.14322. Epub 2020 May 13.
Nickel is the most frequent cause of T cell-mediated allergic contact dermatitis worldwide. In vitro, CD4+ T cells from all donors respond to nickel but the involved αβ T cell receptor (TCR) repertoire has not been comprehensively analyzed.
We introduce CD154 (CD40L) upregulation as a fast, unbiased, and quantitative method to detect nickel-specific CD4+ T cells ex vivo in blood of clinically characterized allergic and non allergic donors. Naïve (CCR7+ CD45RA+) and memory (not naïve) CD154+ CD4+ T cells were analyzed by flow cytometry after 5 hours of stimulation with 200 µmol/L NiSO ., TCR α- and β-chains of sorted nickel-specific and control cells were studied by high-throughput sequencing.
Stimulation of PBMCs with NiSO induced CD154 expression on ~0.1% (mean) of naïve and memory CD4+ T cells. In allergic donors with recent positive patch test, memory frequencies further increased ~13-fold and were associated with markers of in vivo activation. CD154 expression was TCR-mediated since single clones could be specifically restimulated. Among nickel-specific CD4+ T cells of allergic and non allergic donors, TCRs expressing the α-chain segment TRAV9-2 or a histidine in their α- or β-chain complementarity determining region 3 (CDR3) were highly overrepresented.
Induced CD154 expression represents a reliable method to study nickel-specific CD4+ T cells. TCRs with particular features respond in all donors, while strongly increased blood frequencies indicate nickel allergy for some donors. Our approach may be extended to other contact allergens for the further development of diagnostic and predictive in vitro tests.
镍是全球范围内T细胞介导的过敏性接触性皮炎最常见的病因。在体外,所有供体的CD4+ T细胞均对镍产生反应,但尚未对所涉及的αβ T细胞受体(TCR)库进行全面分析。
我们引入CD154(CD40L)上调作为一种快速、无偏差且定量的方法,用于在具有临床特征的过敏和非过敏供体的血液中离体检测镍特异性CD4+ T细胞。在用200 μmol/L NiSO刺激5小时后,通过流式细胞术分析初始(CCR7+ CD45RA+)和记忆(非初始)CD154+ CD4+ T细胞。通过高通量测序研究分选的镍特异性细胞和对照细胞的TCR α链和β链。
用NiSO刺激外周血单核细胞(PBMC)可诱导约0.1%(平均值)的初始和记忆CD4+ T细胞表达CD154。在近期斑贴试验呈阳性的过敏供体中,记忆频率进一步增加约13倍,且与体内活化标记物相关。CD154表达是由TCR介导的,因为单个克隆可被特异性再次刺激。在过敏和非过敏供体的镍特异性CD4+ T细胞中,表达α链片段TRAV9-2或在其α或β链互补决定区3(CDR3)中有组氨酸的TCR高度富集。
诱导的CD154表达是研究镍特异性CD4+ T细胞的可靠方法。具有特定特征的TCR在所有供体中均有反应,而血液中频率的显著增加表明部分供体对镍过敏。我们的方法可扩展至其他接触性过敏原,以进一步开发诊断和预测性体外试验。